Intrathecal dynorphins suppress hindlimb electromyographic activity in rats

Craig Stevens, Matthew B. Weinger, Tony L. Yaksh

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Intrathecal administration of dynorphin A-(1-17) produced suppression of hindlimb electromyographic activity in rats. This effect was seen also with the [D-Ala2]dynorphin (A-(1-17) analog. Intrathecal saline or the prototypical κ opiate agonist, U50488, did not produce any change in electromyographic activity. These results, along with others, suggest that dynorphin or degradation fragment(s) of dynorphin, induces inhibition of ventral horn output and may possibly have toxic effects on ventral horn cells of the spinal cord.

Original languageEnglish
Pages (from-to)299-302
Number of pages4
JournalEuropean Journal of Pharmacology
Volume138
Issue number2
DOIs
StatePublished - 19 Jun 1987

Fingerprint

Dynorphins
Hindlimb
Opiate Alkaloids
Anterior Horn Cells
Poisons
Horns
Spinal Cord

Keywords

  • (Intrathecal administration)
  • Dynorphin A-(1-17)
  • Motor dysfunction
  • U50488
  • κ Opiates

Cite this

Stevens, Craig ; Weinger, Matthew B. ; Yaksh, Tony L. / Intrathecal dynorphins suppress hindlimb electromyographic activity in rats. In: European Journal of Pharmacology. 1987 ; Vol. 138, No. 2. pp. 299-302.
@article{8ac9ae057d34445bab8174c3b045a663,
title = "Intrathecal dynorphins suppress hindlimb electromyographic activity in rats",
abstract = "Intrathecal administration of dynorphin A-(1-17) produced suppression of hindlimb electromyographic activity in rats. This effect was seen also with the [D-Ala2]dynorphin (A-(1-17) analog. Intrathecal saline or the prototypical κ opiate agonist, U50488, did not produce any change in electromyographic activity. These results, along with others, suggest that dynorphin or degradation fragment(s) of dynorphin, induces inhibition of ventral horn output and may possibly have toxic effects on ventral horn cells of the spinal cord.",
keywords = "(Intrathecal administration), Dynorphin A-(1-17), Motor dysfunction, U50488, κ Opiates",
author = "Craig Stevens and Weinger, {Matthew B.} and Yaksh, {Tony L.}",
year = "1987",
month = "6",
day = "19",
doi = "10.1016/0014-2999(87)90449-3",
language = "English",
volume = "138",
pages = "299--302",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

Intrathecal dynorphins suppress hindlimb electromyographic activity in rats. / Stevens, Craig; Weinger, Matthew B.; Yaksh, Tony L.

In: European Journal of Pharmacology, Vol. 138, No. 2, 19.06.1987, p. 299-302.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intrathecal dynorphins suppress hindlimb electromyographic activity in rats

AU - Stevens, Craig

AU - Weinger, Matthew B.

AU - Yaksh, Tony L.

PY - 1987/6/19

Y1 - 1987/6/19

N2 - Intrathecal administration of dynorphin A-(1-17) produced suppression of hindlimb electromyographic activity in rats. This effect was seen also with the [D-Ala2]dynorphin (A-(1-17) analog. Intrathecal saline or the prototypical κ opiate agonist, U50488, did not produce any change in electromyographic activity. These results, along with others, suggest that dynorphin or degradation fragment(s) of dynorphin, induces inhibition of ventral horn output and may possibly have toxic effects on ventral horn cells of the spinal cord.

AB - Intrathecal administration of dynorphin A-(1-17) produced suppression of hindlimb electromyographic activity in rats. This effect was seen also with the [D-Ala2]dynorphin (A-(1-17) analog. Intrathecal saline or the prototypical κ opiate agonist, U50488, did not produce any change in electromyographic activity. These results, along with others, suggest that dynorphin or degradation fragment(s) of dynorphin, induces inhibition of ventral horn output and may possibly have toxic effects on ventral horn cells of the spinal cord.

KW - (Intrathecal administration)

KW - Dynorphin A-(1-17)

KW - Motor dysfunction

KW - U50488

KW - κ Opiates

UR - http://www.scopus.com/inward/record.url?scp=0023182990&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(87)90449-3

DO - 10.1016/0014-2999(87)90449-3

M3 - Article

C2 - 2887441

AN - SCOPUS:0023182990

VL - 138

SP - 299

EP - 302

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -